Coherus BioSciences Inc (CHRS)

17.96 +0.34  +1.93% NASDAQ Dec 7, 16:00 17.95 -0.01  -0.06% After-Hours: 20:00 USD
View Full Chart
Price Chart
View All CHRS News

News

View All Events

Events

Date Type Description
02/24/2022 Earnings Results Q4 2021 Earnings Results
02/24/2022 16:30 EST Earnings Calls Q4 2021 Earnings Call
11/08/2021 Earnings Results Q3 2021 Earnings Results
11/08/2021 17:00 EST Earnings Calls Q3 2021 Earnings Call
08/05/2021 Earnings Results Q2 2021 Earnings Results
08/05/2021 17:00 EST Earnings Calls Q2 2021 Earnings Call
05/21/2021 16:00 EST AGM 2020 Annual General Meeting
05/06/2021 Earnings Results Q1 2021 Earnings Results
05/06/2021 16:30 EST Earnings Calls Q1 2021 Earnings Call
02/24/2021 Earnings Results Q4 2020 Earnings Results
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • Description: Coherus BioSciences Inc is a United States based biotherapeutics company engaged in developing and commercializing biosimilar therapeutics. The company focuses on process science, analytical characterization, protein production, and clinical-regulatory development. Its pipeline includes Immunology, anti-tumor necrosis factor (Anti-TNF) biosimilar candidates; Ophthalmology biosimilar candidates; and Oncology Biosimilar candidates. Geographically, the group has a business presence in the United States and other countries.
  • URL: http://www.coherus.com
  • Investor Relations URL: https://investors.coherus.com
  • HQ State/Province: California
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Growth
  • Next Earnings Release: Feb. 24, 2022
  • Last Earnings Release: Nov. 08, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Top Fund Holders

Symbol Name Weighting
F000015ZK6 ST Healthcare Innovations 10 F RE 4.06%
HSZCX Highland Small-Cap Equity C 3.34%
DGQIX AmericaFirst Defensive Growth I 2.20%
AHSCX Alger Health Sciences C 2.02%
RZG Invesco S&P SmallCap 600® Pure Gr ETF 1.14%
JUSYX JPMorgan US Small Company R5 0.63%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.